New antimalarial more effective than current treatment, but no improvement in adverse birth outcomes

A large LSTM-led trial confirms new antimalarial, dihydroartemisinin-piperaquine, is more effective at preventing malaria than current WHO recommended treatment but does not improve adverse birth outcomes.

source https://medicalxpress.com/news/2023-03-antimalarial-effective-current-treatment-adverse.html